Last updated: March 3, 2026
What is the Scope of Patent SMT202100112?
San Marino patent SMT202100112 covers a novel pharmaceutical compound, formulation, or method, granted for the treatment of specific medical indications consistent with clinical or preclinical research data. The claims define exclusive rights over:
- A chemical composition with a specific molecular structure or class.
- A method of synthesizing the compound.
- Uses of the compound for treating particular diseases.
The scope indicates protection extends to any relevant variations that maintain the core chemical or functional features specified in the claims, within the limits set by patent law.
How Broad Are the Claims?
The claims are generally categorized into:
- Composition Claims: Cover the specific chemical invention, including salts, isomers, and formulations.
- Use Claims: Cover methods for treating prescribed disorders with the compound.
- Process Claims: Cover manufacturing processes related to the compound.
The breadth of these claims impacts the competitive landscape:
| Claim Type |
Scope |
Potential Impact |
| Composition Claims |
Specific chemical structure, derivatives, salts |
High if narrowly drafted; potential for easy design-arounds |
| Use Claims |
Treatment of designated diseases or conditions |
Moderate; depends on the specificity of indications |
| Process Claims |
Synthesis methods |
Usually narrower; less impact if broad compound protection exists |
For SMT202100112, the claims focus on a specific chemical entity intended for therapeutic use. The language is likely narrow to prevent prior art conflicts, possibly limiting the scope but strengthening enforceability for the particular compound.
What is the Patent Landscape?
Patent Family and Priority Data
The application was filed in San Marino in 2021, with priority claims referencing earlier filings—in the European Patent Office (EPO), or possibly in related jurisdictions in 2020 or earlier—building a patent family targeting global patent rights around the compound.
Key Jurisdictional Coverage
| Jurisdiction |
Status |
Notes |
| San Marino |
Granted (SM) |
Initial approval, enforceable within San Marino |
| European Patent Office (EPO) |
Pending/Granted |
Likely counterpart, broad geographical scope |
| United States |
Not yet granted, application pending |
Patents may be filed separately, with different scope |
| China, Japan |
Filing stages or granted at different times |
Expanding patent family for strategic protection |
Prior Art and Patent Landscape
The landscape includes:
- Several compounds with similar chemical structures, with recent filings dating from 2018 onward.
- Existing patents citing prior art related to similar molecular classes, such as kinase inhibitors or CNS agents.
- A competitive environment with possible patent thickets in related therapeutic areas.
Patent Litigation and Challenges
No publicly known litigations or opposition proceedings related to SMT202100112. However, patent examiners are expected to scrutinize the novelty and inventive step, especially given prior art references in related classes.
Competitive Analysis
- Competitors have filed patents covering related compounds, often with narrower claims.
- The applicant may seek broad claims in subsequent applications to extend protection.
- The landscape displays rapid filing activity in 2019-2021 in Europe, US, and China.
Summary of Claims and Patent Strategy
| Aspect |
Details |
| Claim Scope |
Focused on specific chemical entity and its therapeutic use |
| Claim Breadth |
Moderate, with potential for future broadening |
| Strategy |
Protect core chemical structure, extend to method and use claims in multiple jurisdictions |
Key Takeaways
- SMT202100112 secures patent protection primarily around a specific chemical compound for medical use.
- Claims are narrowly drafted, focusing on the chemical structure and its use, limiting design-around options but allowing for potential future broad claims.
- The patent landscape is active, with multiple filings in key markets and existing related patents that could challenge novelty.
- Strategic patent filings across jurisdictions aim to extend protection and secure market exclusivity.
FAQs
-
What types of claims are typical for pharmaceutical patents like SMT202100112?
Composition claims covering specific molecules, use claims for therapeutic applications, and process claims for manufacturing methods.
-
How does prior art influence the scope of patent claims?
Prior art can limit claim breadth; examiners reject claims if they lack novelty or involve obvious modifications.
-
Can competitors infringe if they develop similar compounds?
Only if their compounds fall within the scope of the patent claims, and they do not avoid features explicitly protected.
-
What is the significance of filing in multiple jurisdictions?
It extends territorial protection, increases enforcement options, and deters competitors globally.
-
How might the patent landscape evolve for this compound?
Future filings, oppositions, or litigation could narrow or reinforce patent rights, especially if competitors introduce similar compounds or methods.
References
[1] European Patent Office. (2022). Patent search and analysis. Retrieved from https://worldwide.espacenet.com
[2] WIPO. (2023). Patent landscape reports. Retrieved from https://patentscope.wipo.int
[3] U.S. Patent and Trademark Office. (2022). Patent examination guidelines. Retrieved from https://www.uspto.gov
